Abstract The human angiotensin converting enzyme (ACE) gene is one of the most investigated candidate genes for cardiovascular diseases (CVD), but the understanding of its role among the elderly is vague. Therefore, this study focuses at: (a) testing the association of ACE polymorphism with CVD risk factors among the elderly, and (b) detecting the possible unequal distribution of ACE genotypes between senescent and younger segments of the European populations. The association of ACE I/D polymorphism with CVD health status [hypertension (HT), obesity, dislypidemia] in 301 very old subjects (88.2±5 years; F/M=221/80) was tested by means of logistic regression analysis. The meta-analysis of D allele frequency in general vs. elderly (80+ years) groups was conducted using all publicly available data for European populations comprising both age cohorts. Multiple multinomial logistic regression revealed that within this elderly sample, age (younger olds, 80-90 years), female sex (OR=3.13, 95% CI= 1.59-6.19), and elevated triglycerides (OR=2.53, 95% CI=1.29-4.95) were positively associated with HT, while ACE polymorphism was not. It was also established that the DD genotype was twice as high in 80+ cohort compared to general population of Croatia (p<0.00001). This trend was confirmed by the metaanalysis that showed higher D allele frequencies in olds from nine of ten considered European populations (OR=1.19, 95% CI=1.08-1.31). The data in elderly cohort do not confirm previously reported role of ACE DD genotype to the development of HT. Moreover, meta-analysis indicated that ACE D allele has some selective advantage that contributes to longevity in majority of European populations.
most common cause of death in 2009 for both men and women, constituting over 39% of all deaths (Croatian Bureau of Statistics 1992).
The human angiotensin converting enzyme gene (ACE gene) is one of the most investigated candidate genes for CVD. It converts angiotensin I into a physiologically active angiotensin II, which is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure (BP) and fluid electrolyte balance. ACE also degrades bradykinin to inactive fragments, reducing the serum levels of endogenous vasodilators (Brewster and Perazella 2004; Fleming 2006) . The insertion or deletion (I/D) of a 287-bp-long Alu repeat element in the intron 16 of this gene was proven associated with the altered levels of circulating ACE enzyme (Rigat et al. 1990 ) as well as with cardiovascular pathophysiologies (Cambien et al. 1992; Jeunemaitre et al. 1992a; Keavney et al. 1995) . Some of the conducted studies showed positive association of DD genotype and increased risk of myocardial infarction and atherosclerosis (AgerholmLarsen et al. 2000; Sayed-Tabatabaei et al. 2003) . However, a great number of studies, including metaanalyses, associating ACE I/D with hypertension (HT), cardiomyopathy, and coronary arthery disease showed controversial results (Jeunemaitre et al. 1992b Lindpaintner et al. 1995; Staessen et al. 1997; Sharma 1998; Dikmen et al. 2006; Xu et al. 2008; VaisiRaygani et al. 2010) . Furthermore, recent studies have unravelled roles of the renin-angiotensin system (RAS) and, particularly, its main effector molecule angiotensin II in inflammation, autoimmunity, and aging (Papadopoulos et al. 2000; Pueyo et al. 2000; Suzuki et al. 2003; Kitayama et al. 2006; de Cavanagh et al. 2007; Platten et al. 2009; Benigni et al. 2010) .
Although widely explored, the contribution of ACE I/D and plenty other genetic and environmental risk factors across age spectrum is still unclear. Given the fact that our sample consists of 80 years old and older subjects in rather good physical and mental condition, it is plausible to expect that they have some protective factors that contributed to their good health and longevity. Therefore, we hypothesize that ACE I/ D frequencies differ across population age distribution as a consequence of its association with CVD, its risk factors, and hence mortality.
As HT is recognized as one of the main CVD risk factors (Clarke et al. 2009) , in this study, we will first investigate the effect of ACE I/D polymorphism on HT in a Croatian 80+ years population. Furthermore, we will test the association between ACE I/D polymorphism and longevity comparing our sample with previously reported frequencies for the general Croatian population aged 18-80 years (Barbalić et al. 2004) . Finally, to test whether I/D allele frequency trend really exists, we will conduct a meta-analysis for both general and 80+ population for the allele frequency distribution in European populations.
Materials and methods

Subjects
A field study was carried out from 2007 to 2009. Participants were recruited from all 11 homes for elderly and infirm in the property of the City of Zagreb, and two private homes located in Zagreb County. The 80 years old and older residents were invited to participate voluntarily, and they all signed written, informed consent. Altogether, 301 examinees participated in this study (222 women, 79 men, age range 80-101 years, mean 88.2±5 years). This sample represents 2.86% of the population of Zagreb City in the age group 80+ years (Croatian Bureau of Statistics 1992).
Study protocol
The study protocol was approved by the Ethics Committee of the Institute for Anthropological Research. It consisted of an extensive interview including the mini-mental state examination, the mini nutritional assessment, BP measurement, short anthropometry, ultrasound measurement of bone mineral density, and collection of venipuncture specimens for biochemical parameters and genetic analyses. Questionnaire included detailed questions regarding sociodemographic status, health status, medical history, nutritional habits, and examinee's satisfaction with his/her quality of life. Trained examiners filled out a questionnaire during a face-to-face interview. Only subset of the obtained data is presented here and explained in more details.
Short anthropometry was undertaken following standard international biological programme protocol (Weiner and Lourie 1981) . Body mass index (BMI) was calculated as weight in kilograms divided by squared height in meters (kg/m 2 ). On the basis of BMI (WHO Classification; WHO 2000) , subjects were divided into three groups: underweight (BMI< 18.50 kg/m 2 ), normal .99 kg/m 2 ), and overweight (BMI≥25 kg/m 2 ). BP was measured in a seated position by the physician using a standard mercury sphygmomanometer and stethoscope after participants rested for 15 min. The selection criteria for hypertensive cases were any of the following: systolic BP equal to or higher than 140 mmHg, diastolic BP equal to or higher than 90 mmHg, subject's statement that she/he is hypertensive (indicating previous diagnosis of HT by personal physician), and subject's drug treatment history of HT.
Whole blood samples were obtained by venipuncture and collected for every subject into three tubes for the following analyses: blood serum biochemical analyses, hematological analysis, and DNA extraction. Serum and blood cells analyses were performed following standard internationally agreed procedures. Biochemical analysis included triglyceride and cholesterol measurements [total, high-density and lowdensity lipoprotein cholesterol (HDL and LDL), and atherosclerosis index].
ACE genotyping
DNAwas extracted by a salting-out method (Miller et al. 1988) . Genomic DNA was amplified by polymerase chain reaction (PCR) with primers 5′-CTG GAG ACC ACT CCC ATC CTT TCT-3′ (forward) and 5′-GAT GTG GCC ATC ACA TTC GTC AGA T-3′ (reverse). PCR cycling was in a touchdown regime described previously (Kalaydjieva et al. 1999) .
The PCR products, 490-bp-long (I) and 190-bp-long (D) fragments, were analyzed by agarose gel electrophoresis using 2%-agarose gel and visualized with SYBR Gold stain. 
Statistical analysis
We determined ACE ID genotype frequencies by direct counting, and allele frequencies were calculated from the genotype frequencies. The Hardy-Weinberg equilibrium (HWE) was evaluated by the Chi-square (χ 2 ) test. We tested differences in CVD risk factors between sexes using Fisher's exact test and Pearson's Chi-square test. Same factors were analyzed using t test in hypertensives vs. nonhypertensives.
Several multivariate logistic regression models were tested to verify the combined effect of several risk factors on HT, and the best regression model was taken into account. The following variables were tested: age, sex, BMI, waist/hip ratio, cholesterol (total, HDL, and LDL) and triglyceride serum levels, ACE ID genotypes and I and D alleles frequency. The analyses were performed by SPSS 10.0 statistical package for Windows (SPSS, Chicago, IL, USA), with statistical significance set at p<0.05.
Meta-analysis was performed to further investigate the association of ACE D allele with longevity in European populations using Stata 10 (Stata Corporation, College Station, TX, USA). The odds ratio (OR) was Age data in this table are not presented uniformly because they were reported differently in the papers: some authors preferred age range, others mean age (SD) or just reported that subjects were over a certain age. We divided them in two groups: group one, for subjects aged 18-80 years, and group two, for those aged 80+ years (or if the mean age of the entire group was 80+). Each study group consisted of both females and males. Genotype distribution is reported in absolute numbers.
used to compare contrasts of alleles between general population and senescents. Data were combined using random effects method (Mantel-Haenszel) and fixed effects method (Der Simonian and Laird). The betweenpopulation heterogeneity was evaluated using the χ 2 -based Cochran's Q statistic (Petiti 1994 ) and the inconsistency index (I 2 ; Higgins et al. 2003) . Publication bias or other small study related bias was evaluated using the rank correlation method of Begg and Mazumdar and fixed effects regression method of Egger et al. (1997) .
To identify potential influential studies (countries), we calculated the effects estimates (ORs) by removing an individual study each time and then checked if the overall significance of the estimate or of the heterogeneity statistics was altered. Due to the composite nature of each country's sample, cumulative and metaregression analysis could not be assesed.
Results
The examined CVD risk factors are shown in Table 2 . Women had significantly elevated total cholesterol (p<0.000), LDL cholesterol (p<0.000), and triglyceride level (p<0.001) compared to men. The majority of the subjects were hypertensive, although the average BP was normal (below 140/90 mmHG), indicating adequate medical treatment. In Table 3 , we compared the distribution of CVD risk factors in normotensive and hypertensive subjects. Hypertensives were more likely to be younger (87.55 vs. 88.65 years) and to have elevated HDL cholesterol (p<0.03).
Of the investigated risk factors, multivariate logistic regression showed that age (younger olds, 80-90 years), female sex (OR=3.13: 95% CI=1.59-6.19), and elevated triglyceride concentration (OR= 2,53: 95% CI=1.29-4.95) had significant influence on incidence of HT, while ACE genotype, BMI, waist/hip ratio, and cholesterol concentration did not (Table 4) . In order to test the association between ACE I/D polymorphism and longevity, we used previously reported frequencies for the general Croatian population (Barbalić et al. 2004 ). The genotype distribution in general population was compatible with HWE, but it was not the case in 80+ years population where we found a lack of heterozygotes (p=0.000061, df=1). The ACE genotype (II, ID, and DD) distribution differed significantly between two age cohorts with DD genotype being twice as frequent in senescents as in the younger cohort. D allele frequency was also higher in elderlies (Table 5 ). Both ACE I/D genotype (p<0.00001) and allele (p<0.001) distribution differences between general and 80+ population were statistically significant. The ACE genotype and allele distributions were not significantly different between our NT and HT senescent groups (p>0.05).
The results of the meta-analysis are presented in Fig. 1 . In nine of ten analyzed countries (with the exception of Spain), D allele frequencies were higher in elderlies than in general population; individual ORs were statistically significant as well as the total OR amounting 1.19 (95% CI, 1.08-1.31; Fig. 1 ). Since the Cochrane Q test result indicated that the heterogeneity was low (I 2 <11%, p=0.346), the data were pooled by means of the fixed effect model (MantelHaenszel method).
Using Begg's (p>0.788) and Egger's test (p>0.799) as well as by visual inspection of the funnel plot (Fig. 2) , we found no evidence for publication bias. The influential analysis revealed that no single study (country) was responsible for the overall significance of the estimates (Fig. 3) . After removing an individual study each time and recalculating the combined estimates, the overall estimates as well as the heterogeneity statistics remained nearly unchanged. For the includued studies performed by the same research group, we examined the materials and methods sections and assured that these studies contained no overlapping sets of individuals.
Discussion
Numerous worldwide conducted studies have demonstrated that elevated BP is one of the major risk factors for developing cardiovascular diseases. However, only few have tested the association between candidate genes and CVD risk factors in elderly cohort. This study provides information on the ACE I/D polymorphism, HT, dislypidemia, and BMI in Croatian elderly population. We did not confirm previously reported role of the investigated risk factors to the development of HT in our 80+ years cohort. Probably the most remarkable finding from this study is a detection of significantly more D allele carriers among elderlies than in general population, suggesting that ACE D allele contributes to good health and longevity. The best model included ACE I/D genotypes, age (younger olds, 80-90 years, and older olds, ≥91 years), sex, and triglyceride blood concentration (<1.70 mmol/l and ≥1.70 mmol/l) *p=0.01; **p=0.001; ***p=0.006 The prevalence of HT in our 80+ subjects was thrice as high as the prevalence in Croatian general Meta-analysis of ACE I/D D allele distribution in ten European countries (LloydJones et al. 2005) . These findings are in concordance with pathophysiological changes that occur in the cardiovascular system with aging: decreasing elasticity of the aorta and great arteries, a dropout of myocytes that together with the increased left ventricular (LV) afterload results in modest LV hypertrophy, apoptosis of atrial pacemaker cells, and HT as a consequence of all that (Yin et al. 1982; Vaitkevicius et al. 1993; Cheitlin and Zipes 2001) . However, some observations have shown that BP level is closely related to the risk of stroke and heart disease, but the association declines with increasing age (Prospective Studies Collaboration 1995). Considering our finding that HT is more prevalent in women than in men, it is not a surprise that in women, we also detected significantly elevated biochemical risk factors for CVD: total cholesterol, LDL cholesterol, and triglyceride level. Logistic regression of risk factors for HT showed statistically significant contribution of female sex, triglyceride concentration, and age (younger elderlies, <91 years) to the prevalence of HT. The higher prevalence of HT in women than in men in our study is consistent with the results of Martins et al. (2001) , where he concluded that women have higher rates of HT than men as they age. The prevalence of CVD in women is low during the reproductive years and after menopause women's risk rises from two to three times. Carlson et al. (2004) reported that a decrease in estrogen production leads to the development of atherosclerosis. In a recent review, Labreuche et al. (2010) found a positive association between elevated triglyceride levels and stroke and carotid atherosclerosis.
The role of the ACE gene in the pathogenesis of HT is well known and documented (Jeunemaitre et al. 1992a ), yet many ACE I/D genotype distribution results in hypertensive vs. nonhypertensive subjects are contradictory (Szadkowska et al. 2006; Freitas et al. 2007; Miyama et al. 2007 ). Some explain this inconsistency with genetic and environmental heterogeneity between different ethnic groups (Bautista et al. 2004; Zhang et al. 2007; Higaki et al. 2000; Jiménez et al. 2007; Companioni Nápoles et al. 2007) as well as ACE I/D polymorphism gene's complex interaction with other genetic factors that contribute to the expression of HT (Nawaz and Hasnain 2008) .
Previously reported results pointed to the association of ACE D polymorphism with HT in general Croatian population , while in 80+ years Meta-analysis fixed-effects estimates (exponential form) Fig. 3 Influential metaanalysis plot with the effects estimates (ORs) after omiting an individual study each time population, we did not confirm it. Our findings do not support population-specific, but age-conditioned association of ACE I/D genotype with HT. The first study of ACE I/D genotype distribution within centenarians and controls, conducted by Schachter et al. (1994) , reported unexpectedly frequent occurrence of DD genotype in the French centenarians compared with the control group (40% vs. 26%, p= 0.01). The experiment was repeated in 2000 with nearly twice that sample, but the results failed to confirm previous findings (Blanche et al. 2001) . Neither the Rotterdam study results (Arias-Vasquez et al. 2005) nor the results of the Italian study (Nacmias et al. 2007) suggested any relation of ACE I/D polymorphism with longevity. Then again, Lufts group observed that in German population over 80 years, D allele occurred at higher frequency than in youngs (Luft 1999) .
Considering widely investigated role of ACE I/D polymorphism in various diseases, namely, CVD, Alzheimer's disease, sarcoidosis, and others, allele frequencies are reported in numerous studies for different age groups. Since the said longevity studies results were inconclusive, we conducted a meta-analysis in both healthy general and 80+ European populations. In the analysis, we included subjects that represented healthy controls for D allele frequencies in various diseases, as well as the subjects from previously mentioned longevity studies. It is possible that some relevant studies were not included in our review, as we limited our search to reports published in English. With the only exception of Spain, the results from all available countries were similar to ours; ACE gene D allele frequencies were higher in subjects 80+ years than in general adult population.
Schahter's group proposed that the risk of developing CVD conferred by the D allele is redeemed by a possible long-term protective effect; such an effect may give some early selective advantage and/or a late reversal of its negative survival influence. They also suggested a potential relation of protective effect of DD genotype to other biological functions of ACE besides in RAS and kinin-kallikrein systems: neuroendocrine and immunomodulator functions related to ACE levels may contribute to overall survival and longevity (Ehlers and Riordan 1989; McGeer and Singh 1992; Costerousse et al. 1993) . The association of DD genotype with longevity may also be derived from linkage disequilibrium to a closely mapping gene still to be identified. In addition, it is interesting to mention that a gene encoding for the human growth hormone also maps to chromosome 17q23, shows strong linkage to ACE, and appears to have an important role in senescence (McGeer and Singh 1992; Crisan and Carr 2000; Huang et al. 2007) .
Comparing centenarians and middle-aged controls from Italy, France, and Denmark, Panza et al. (2003) reported a decrease, although statistically insignificant, in ACE I allele frequencies from North to South of Europe in both age groups. In 2004, Barbalić graphically presented the worldwide frequency distribution of ACE Alu insertion, where she reported lowest frequency of I allele in Africa, which increases toward Asia and Australia on one side and the Americas on the other with general Croatian population frequency of 50.06% falling within the range of European populations. We found no geographical gradient of ACE D allele in our meta-analysis, neither in general nor in 80+ populations.
In conclusion, we presented in this study that the ACE D allele was not associated with HT in Croatian senescent population, regardless of its well-known role in BP regulation and direct impact at CVD development. ACE DD genotype and D allele frequency were more frequent among the senescents than in general Croatian population. Such genetic differences, which were confirmed with meta-analysis including other European populations, indicate that D allele, apart from being CVD risk factor in middleaged population, might have some, yet unrecognized, advantageous role in successful human aging.
